Cargando…

Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C

BACKGROUND: Interferon (IFN)-α receptor 1 (ifnar1) and suppressor of cytokine signaling 1 (socs1) transcription levels were quantified in peripheral blood mononuclear cells (PBMC) of 59 patients infected with hepatitis C virus (HCV) and 17 non-infected individuals. Samples were obtained from patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Sedeño-Monge, Virginia, Santos-López, Gerardo, Rocha-Gracia, Rosa C, Meléndez-Mena, Daniel, Ramírez-Mata, Alberto, Vallejo-Ruiz, Verónica, Reyes-Leyva, Julio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949844/
https://www.ncbi.nlm.nih.gov/pubmed/20849643
http://dx.doi.org/10.1186/1743-422X-7-243
_version_ 1782187593792749568
author Sedeño-Monge, Virginia
Santos-López, Gerardo
Rocha-Gracia, Rosa C
Meléndez-Mena, Daniel
Ramírez-Mata, Alberto
Vallejo-Ruiz, Verónica
Reyes-Leyva, Julio
author_facet Sedeño-Monge, Virginia
Santos-López, Gerardo
Rocha-Gracia, Rosa C
Meléndez-Mena, Daniel
Ramírez-Mata, Alberto
Vallejo-Ruiz, Verónica
Reyes-Leyva, Julio
author_sort Sedeño-Monge, Virginia
collection PubMed
description BACKGROUND: Interferon (IFN)-α receptor 1 (ifnar1) and suppressor of cytokine signaling 1 (socs1) transcription levels were quantified in peripheral blood mononuclear cells (PBMC) of 59 patients infected with hepatitis C virus (HCV) and 17 non-infected individuals. Samples were obtained from patients infected with HCV that were either untreated or treated with IFN-α2 plus ribavirin for 1 year and divided into responders and non-responders based on viral load reduction 6 months after treatment. Ifnar1 and socs1 transcription was quantified by real-time RT-PCR, and the fold difference (2(-ΔΔCT)) with respect to hprt housekeeping gene was calculated. RESULTS: Ifnar1 transcription increased significantly in HCV-infected patients either untreated (3.26 ± 0.31), responders (3.1 ± 0.23) and non-responders (2.18 ± 0.23) with respect to non-infected individuals (1 ± 0.34; P = 0.005). Ifnar1 transcription increased significantly (P = 0.003) in patients infected with HCV genotypes 1a (4.74 ± 0.25) and 1b (2.81 ± 0.25) but not in 1a1b (1.58 ± 0.21). No association was found of Ifnar1 transcription with disease progress, initial viral load or other clinical factors. With respect to socs1 transcription, values were similar for non-infected individuals (1 ± 0.28) and untreated patients (0.99 ± 0.41) but increased in responders (2.81 ± 0.17) and non-responder patients (1.67 ± 0.41). Difference between responder and non-responder patients was not statistically significant. Socs1 transcription increased in patients infected with HCV genotypes 1a and 1b (2.87 ± 0.45 and 2.22 ± 0.17, respectively) but not in 1a1b (1.28 ± 0.40). Socs1 transcript was absent in three patients infected with HCV genotype 1b. A weak correlation between ifnar1 and socs1 transcription was found, when Spearman's correlation coefficient was calculated. CONCLUSION: Our results suggest that HCV infection may up-regulate ifnar1 transcription. HCV genotypes differ in their capacity to affect ifnar1 and socs1 transcription, as well as in the ability to evade the antiviral response.
format Text
id pubmed-2949844
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29498442010-10-06 Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C Sedeño-Monge, Virginia Santos-López, Gerardo Rocha-Gracia, Rosa C Meléndez-Mena, Daniel Ramírez-Mata, Alberto Vallejo-Ruiz, Verónica Reyes-Leyva, Julio Virol J Research BACKGROUND: Interferon (IFN)-α receptor 1 (ifnar1) and suppressor of cytokine signaling 1 (socs1) transcription levels were quantified in peripheral blood mononuclear cells (PBMC) of 59 patients infected with hepatitis C virus (HCV) and 17 non-infected individuals. Samples were obtained from patients infected with HCV that were either untreated or treated with IFN-α2 plus ribavirin for 1 year and divided into responders and non-responders based on viral load reduction 6 months after treatment. Ifnar1 and socs1 transcription was quantified by real-time RT-PCR, and the fold difference (2(-ΔΔCT)) with respect to hprt housekeeping gene was calculated. RESULTS: Ifnar1 transcription increased significantly in HCV-infected patients either untreated (3.26 ± 0.31), responders (3.1 ± 0.23) and non-responders (2.18 ± 0.23) with respect to non-infected individuals (1 ± 0.34; P = 0.005). Ifnar1 transcription increased significantly (P = 0.003) in patients infected with HCV genotypes 1a (4.74 ± 0.25) and 1b (2.81 ± 0.25) but not in 1a1b (1.58 ± 0.21). No association was found of Ifnar1 transcription with disease progress, initial viral load or other clinical factors. With respect to socs1 transcription, values were similar for non-infected individuals (1 ± 0.28) and untreated patients (0.99 ± 0.41) but increased in responders (2.81 ± 0.17) and non-responder patients (1.67 ± 0.41). Difference between responder and non-responder patients was not statistically significant. Socs1 transcription increased in patients infected with HCV genotypes 1a and 1b (2.87 ± 0.45 and 2.22 ± 0.17, respectively) but not in 1a1b (1.28 ± 0.40). Socs1 transcript was absent in three patients infected with HCV genotype 1b. A weak correlation between ifnar1 and socs1 transcription was found, when Spearman's correlation coefficient was calculated. CONCLUSION: Our results suggest that HCV infection may up-regulate ifnar1 transcription. HCV genotypes differ in their capacity to affect ifnar1 and socs1 transcription, as well as in the ability to evade the antiviral response. BioMed Central 2010-09-18 /pmc/articles/PMC2949844/ /pubmed/20849643 http://dx.doi.org/10.1186/1743-422X-7-243 Text en Copyright ©2010 Sedeño-Monge et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Sedeño-Monge, Virginia
Santos-López, Gerardo
Rocha-Gracia, Rosa C
Meléndez-Mena, Daniel
Ramírez-Mata, Alberto
Vallejo-Ruiz, Verónica
Reyes-Leyva, Julio
Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C
title Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C
title_full Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C
title_fullStr Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C
title_full_unstemmed Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C
title_short Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C
title_sort quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis c
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949844/
https://www.ncbi.nlm.nih.gov/pubmed/20849643
http://dx.doi.org/10.1186/1743-422X-7-243
work_keys_str_mv AT sedenomongevirginia quantitativeanalysisofinterferonalphareceptorsubunit1andsuppressorofcytokinesignaling1genetranscriptioninbloodcellsofpatientswithchronichepatitisc
AT santoslopezgerardo quantitativeanalysisofinterferonalphareceptorsubunit1andsuppressorofcytokinesignaling1genetranscriptioninbloodcellsofpatientswithchronichepatitisc
AT rochagraciarosac quantitativeanalysisofinterferonalphareceptorsubunit1andsuppressorofcytokinesignaling1genetranscriptioninbloodcellsofpatientswithchronichepatitisc
AT melendezmenadaniel quantitativeanalysisofinterferonalphareceptorsubunit1andsuppressorofcytokinesignaling1genetranscriptioninbloodcellsofpatientswithchronichepatitisc
AT ramirezmataalberto quantitativeanalysisofinterferonalphareceptorsubunit1andsuppressorofcytokinesignaling1genetranscriptioninbloodcellsofpatientswithchronichepatitisc
AT vallejoruizveronica quantitativeanalysisofinterferonalphareceptorsubunit1andsuppressorofcytokinesignaling1genetranscriptioninbloodcellsofpatientswithchronichepatitisc
AT reyesleyvajulio quantitativeanalysisofinterferonalphareceptorsubunit1andsuppressorofcytokinesignaling1genetranscriptioninbloodcellsofpatientswithchronichepatitisc